首页 | 医院概况 | 组织结构 | 新闻中心 | 科研成果 | 诊疗中心 | 专家团队 | 重点实验室 | 《医学参考报》 | 联系我们 | 友情链接
新闻中心
科研成果
诊疗中心
医院概况
    哈尔滨医科大学血液肿瘤医院前身为哈尔滨医科大学附属第一医院血液内科,由1959年建立的普通内科血液专业组发展而来。50多年来,经过几代人的不懈努力,发生了翻天覆地的变化...[详细]
医院院长
周晋 教授 主任医师
哈尔滨医科大学血液肿瘤医院院长
中文介绍 English
 
 Hou J,Fu Y, Zhou J, Li W, Xie R, Cao F, Gilbert GE, Shi J.Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets. Vox Sang. 2011;100(2):187-95.  2011-09-21
 Lin S, Han B, Yu L, Shan D, Wang R, Ning X.Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer. Nucl Med Commun. 2011;32(6):479-85.  2011-09-21
 Fu Y, Zhou J, Li H, Cao F, Su Y, Fan S, Li Y, Wang S, Li L, Gilbert GE, Shi J. Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. Thromb Haemost. 2010;104(6):1235-41.  2011-09-21
 Cao FL, Liu HH, Wang YH, Liu Y, Zhang XY, Zhao JQ, Sun YM, Zhou J, Zhang L.An optimized RNA amplification method for prokaryotic expression profiling analysis. Appl Microbiol Biotechnol. 2010;87(1):343-52.  2011-09-21
 Zhou J, Shi J, Hou J, Cao F, Zhang Y, Rasmussen JT, Heegaard CW, Gilbert GE. Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia. J Thromb Haemost. 2010 ;8(4):773-82.  2011-09-21
 Zhou J, Zheng Y, Shi J, Lu C, Hou J, Yu H, Qiao X, Qi S, Gilbert GE.Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells. Thromb Res. 2010 ;125(2):178-83.  2011-09-21
 Zhou J, Hu L, Cui Z, Jiang X, Wang G, Krissansen GW, Sun X.Interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome. Int J Hematol. 2010 ;91(2):293-302.  2011-09-21
 Zhou J, Zhang Y, Li J, Li X, Hou J, Zhao Y, Liu X, Han X, Hu L, Wang S, Zhao Y, Zhang Y, Fan S, Lv C, Li L, Zhu L.Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. Blood. 2010;115(9):1697-702.  2011-09-21
 Han L, Wierenga AT, Rozenveld-Geugien M, van de Lande K, Vellenga E, Schuringa JJ.Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses. PLoS One. 2009;4(11):e7989.  2011-09-21
 Wang W, Adachi M, Zhang R, Zhou J, Zhu D.A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Pancreas. 2009 ;38(4):e114-23.  2011-09-21
 Han B, Lin S, Yu LJ, Wang RZ, Wang YY.Correlation of ¹⁸F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun. 2009;30(11):831-7.  2011-09-21
 Tan L, Liu J, Liu X, Chen J, Yan Z, Yang H, Zhang D.Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res. 2009;28:131.  2011-09-21
 Zhou J, Liu S, Ma M, Hou J, Yu H, Lu C, Gilbert GE, Shi J.Procoagulant activity and phosphatidylserine of amniotic fluid cells. Thromb Haemost. 2009 ;101(5):845-51.  2011-09-21
 Zheng YN, Yu HJ, Hou JX, Lu CF, Zhou J.Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis. Chin Med J (Engl). 2009;122(14):1674-80.  2011-09-21
 Lü CF, Yu HJ, Hou JX, Zhou J. Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J (Engl). 2008;121(18):1775-80.  2011-09-21
 Zhou J, Wang W, Wei QF, Feng TM, Tan LJ, Yang BF.Effects of arsenic trioxide on voltage-dependent potassium channels and on cell proliferation of human multiple myeloma cells. Chin Med J (Engl). 2007;120(14):1266-9.  2011-09-21
 Wang W, Adachi M, Kawamura R, Sakamoto H, Hayashi T, Ishida T, Imai K, Shinomura Y.Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis. 2006 ;11(12):2225-35.  2011-09-21
 Han LN, Zhou J, Hirose T, Imai Y, Ishiguro T, Chou T. Feasibility and efficacy of high-dose melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) chemotherapy with or without rituximab followed by autologous stem cell transplantation for aggressive and relapsed non-Hodgkin's lymphoma. Int J Hematol. 2006;84(2):174-81.  2011-09-21
[首页] [上页] [下页] [尾页]
 当前第1页/共22条/2页

哈尔滨医科大学 哈医大一院
Pubmed检索 《Blood》 《NatureScience Nature AsiaScience Daily
中华人民共和国科学技术部 中华人民共和国教育部 中华人民共和国卫生部 国家自然科学基金委员会 黑龙江科学技术厅
中华医学会 中国医学网 血液健康网 干细胞科学网 科学网
哈尔滨医科大学血液肿瘤医院版权所有 保留所有权利 黑ICP备09002418号 Copyright 20015-2025 hljblood.org.cn All Rights Reserved